
Here's the Best Dividend Stock To Sell Covered Calls on Today
People say that dividend investing is boring, and I get it. After you buy the stock, there's really nothing else left to do but check your portfolio every now and then and wait for the dividends to come in. Then, maybe at some point down the line, you'll sell your dividend stocks for a capital gain.
That is, except for when you throw options trading in the mix.
You see, certain option strategies like covered calls allow you to leverage your long-term dividend stocks, be it a Dividend Aristocrat or King, to boost your profits. Selling covered calls allows you to collect additional income from your dividend stocks in exchange for potentially giving up a little upside. And if you carefully manage your calls, you can repeat the process.
Naturally, if you already own dividend stocks, like, say, Coca-Cola, you can use the Covered Call tool on the asset page to screen for potential call options to sell. Then, you can decide the expiration date and strike that works best for you.
Income investors can earn an additional 0.5% - 1% or more in monthly premiums by selling covered calls.
Today, however, I'll show you how to use Barchart's Option Screener tool to find the best dividend stock you can buy to sell covered calls - right now.
Then, I'll break down the trade and give you risk-mitigation strategies to avoid getting assigned.
Looking For The Right Covered Call Trade
First, let's jump over to Barchart's Covered Call Option Screener. You'll be brought to the results page first.
The default results page is a good start for covered call trades. As you can see, all the relevant details, like premiums, strike prices, expiration dates, percentages, and probabilities, are on display.
However, we're looking for covered calls on dividend stocks like Kings and Aristocrats, so let's click on the Set Filters tab at the top. There, you'll see the default filters for covered calls. I've added some filters and changed the values of some of them to personalize my analysis.
Underliyers Found on the Watchlist: This cross-functional filter allows me to access and search my Barchart Watchlists. As you can see, I've limited the search to Dividend Aristocrats (25 years of straight dividend payment increases) and Kings (50 years), so I know I'm getting good quality dividend stocks on my screens.
Bid Price: This filter indicates how much you can sell the covered call for per share. I set this to $1, so the minimum premium I'll get from the trade results is $100 total.
OTM Probability: This filter gives us an estimated probability of the option expiring out of the money, allowing you to avoid assignment. I'll set this to 70% or more.
And so, with these filters and values, here are the screen results:
These trades are arranged by the highest potential returns by default. The top three trades, all on TGT stock (Target Corp), are pretty decent, but I'd prefer to use the third one, as its expiration date is closer. So, let's break down that trade.
Covered Call on Target: Trade Details
The screen indicates you can buy 100 shares of Target Corporation at $127.39 per share, bringing your initial capital to $12,739. Then, you can write a $140-strike call on that stock position for $2.06 per share or $206 total in premium per contract that expires on March 7, 2025, 10 days from the date of the screen. This trade has a 77.83% chance of expiring out of the money, meaning there's a big chance you get to keep the full $206 (minus trade fees) by expiration.
The trade also has a -0.24084 delta. For a quick reference, delta is an option Greek that tells us how much the premium is expected to change for every $1 change in the underlying stock's price. Traders also use it as a quick indicator to check the probability of an option expiring worthless. Here's a quick reference guide on how to interpret delta for covered calls:
So, if TGT doesn't trade at $140 by March 7, you get to keep your 100 shares - and that's the goal. However, if TGT stock is trading near the strike by expiration, I suggest closing your short options with a buy-to-close order. It will give you some extra peace of mind. You will need to pay a little premium to buy back that short call. However, it'll likely be near zero as options lose value the closer they get to expiration - especially if they are out of the money. Doing so assures there'll be no chance of getting assigned and losing your shares.
The trade also has an annualized return rate of 427.2%. That means if you could sell a 10DTE covered call for $206 (but not necessarily with the same strike price) for the whole year and not get assigned, you could earn back more than 400% of your capital. Of course, that's just a broad overview; the market will change over time, so you'd have to adjust your trades accordingly.
Target also pays $4.48 in annualized dividends, translating to a 3.51% yield, so if you can keep your shares, the income will keep coming.
Rolling Positions and Assignment
On expiration day, one of two things will happen. TGT's stock price will either be higher or lower than the call option strike.
Whatever happens, the ideal situation is for the call to expire worthless, and it happens if the stock trades below the strike at expiration. Then, you can sell another call with a different strike and expiration; rinse and repeat.
If however, the stock is near or exceeds the strike, it's suggested to roll your position. To roll your covered call, start by buying back the call with a buy-to-close order - this will close it out. Then, sell another call with a later expiration date, always paying attention to the OTM probabilities and/or delta. This means the strike will likely be different as well. This is called rolling your position.
IMPORTANT: If you don't roll your position and TGT hits or exceeds $140 at expiration, your short call will be assigned, and your 100 TGT shares will be called away at $140 per share, even if TGT soars above $140. This isn't necessarily terrible, though, as you'll still earn money from the trade - specifically, $12.61 per share from the sale of the stocks plus the $2.06 premium, bringing your net profit to $14.67 or $1,467 per contract. Not a bad payday. Then, you can again use the screener to find another target (an option target, not the company.)
Final Thoughts
Covered calls can be a great way to boost your income while still receiving income from long-term dividend stocks. Sure, it comes with the risk of losing your shares, but with proper risk management, you can avoid assignment and keep getting premiums from options trading.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
a day ago
- Cision Canada
The Hashemite Kingdom of Jordan Announces New Ocean Innovation Hub in Partnership with Innovative Blue Technology Company Voyacy Regen
Located in the Gulf of Aqaba, in the Hashemite Kingdom of Jordan, the Aqaba Marine Park will focus on building climate-resilient coastal marine infrastructure at an unprecedented scale NICE, France, June 9, 2025 /CNW/ -- Today, His Majesty King Abdullah II ibn Al Hussein announced a new partnership with blue technology company Voyacy Regen, cofounded by Philippe and Ashlan Cousteau, to build a new ocean technology accelerator and innovation hub in Aqaba, Jordan. Under the Aqaba Marine Park (AMP) initiative, this groundbreaking project will focus on regenerating coral reefs and critical coastal marine infrastructure at scale to create a climate-resilient world where people and the ocean can thrive. "Today's announcement marks a pivotal step forward in our effort to embed sustainable practices and climate actions as an integral part of Jordan's economic growth, while establishing safeguards that will protect the kingdom's environment and natural resources for future generations," said Hussein Al-Safadi, CEO of Aqaba Development Corporation (ADC). "The Aqaba Marine Park will play a vital role in regenerating coral reefs, strengthening climate resilience, and promoting the sustainable use of ocean resources, in alignment with His Majesty King Abdullah II's vision for Aqaba, and with the guidance and support of the AMP's International Honorary Advisory Board." Coral reefs absorb up to 97% of storm surge and are critical barriers against increasingly catastrophic storms that already cause billions of dollars of damage and threaten millions of lives. However, coral reefs are disappearing at an alarming rate – it's estimated that half of the world's corals have disappeared since the 1950s, with 14% vanishing between 2009 and 2018 alone. "This partnership with the Hashemite Kingdom of Jordan is deeply meaningful to me, and I am honored to be working with His Majesty King Abdullah II," said Philippe Cousteau, Co-founder of Voyacy Regen and Aqaba Marine Park International Honorary Advisory Board Member. "Coastal communities are on the front lines of our rapidly changing world, and we couldn't think of a better partner than Jordan to scale the tangible solutions we need to solve this crisis." Located within the Aqaba Marine Nature Reserve, under ASEZA's supervision, and home to one of the Red Sea's most vibrant coral reefs and marine ecosystems, the Aqaba Marine Park, in cooperation with Voyacy, will focus on large-scale coral reef regeneration and coastal marine infrastructure to help create a climate-resilient future where both people and the ocean can thrive. Traditional methods of coral restoration, which involve growing small batches of corals and planting manually, cannot be implemented at the scale and speed needed to meet this crisis. Utilizing Voyacy's approaches, the Innovation Hub in Aqaba represents a nexus of action that will see the development and implementation of new, best-in-class technologies. The core technology combines 3D-printed reef structures, designed to absorb wave energy, with aquacultured heat-tolerant corals and AI technology. This allows for the rapid and cost-effective deployment of infrastructure that can protect coastal communities against destructive storms while promoting biodiversity. Voyacy and Jordan have mobilized a coral propagation farm and deployed a best-in-class commercial-scale 3D printer in Aqaba to accelerate this technology. About the Aqaba Development Corporation The Aqaba Development Corporation (ADC) is the government's investment arm for Aqaba Special Economic Zone (ASEZ), owning and managing key assets including ports, airport, and land. ADC drives sustainable growth by enabling investment and infrastructure across six priority sectors: tourism, manufacturing, green energy, logistics, creative industries, and education, and leads multiple initiative to support the blue economy. About the Aqaba Special Economic Zone (ASEZA) Launched in 2001, the Aqaba Special Economic Zone (ASEZA) is designed and developed to embody and emphasize His Majesty King Abdullah II's vision for Aqaba. The Royal Vision is committed to transforming Aqaba into a world-class business hub and leisure destination, while putting the community's welfare and preserving the city's environmental and cultural heritage at heart. As Aqaba's transformation plans were set in motion, over the past 24 years, enormous milestones were achieved by mobilizing the Zone's government institutions, community, and the private sector. About Voyacy Regen Founded by Philippe and Ashlan Cousteau, Voyacy Regen is a pioneering blue tech company that combines human ingenuity, breakthrough technology, and innovative partnerships to solve one of the biggest problems facing coastal communities around the world; the collapse of the natural ocean systems that protect us. Voyacy's core technology combines 3D-printed reef structures, designed to absorb wave energy, with aquacultured heat-tolerant corals and AI technology, resulting in a commercially viable solution that will protect coastal communities, build the blue economy, and increase biodiversity. Learn more:


Cision Canada
2 days ago
- Cision Canada
DRI Healthcare Trust Announces Appointment of Annalisa King to Board of Trustees and as Chair of the Audit Committee
– Adds extensive expertise in audit, risk and financial strategy – TORONTO, June 9, 2025 /CNW/ - DRI Healthcare Trust (TSX: (TSX: DHT.U) ("DRI" or "the Trust") today announced Annalisa King has been appointed as an independent member and chair of the audit committee of the Trust's board of trustees effective immediately. Ms. King is the chair of the board for Vancouver Airport Authority and an experienced corporate director serving on three TSX public company boards. She is the chair of the audit committee at both Saputo Inc. and The North West Company Inc. and is the chair of the compensation committee at First Capital Real Estate Investment Trust. In addition to her board work, Ms. King is the National Academic Director of the Board Oversight of Strategy course at the Institute of Corporate Directors. Ms. King was the Senior Vice President and Chief Financial Officer of Best Buy Canada Ltd. from 2008 to 2016, where, in addition to her finance responsibilities, she also led the information technology, ecommerce technology, cyber security, legal and real estate functions. Recognized in 2012 as the British Columbia CFO of the Year by Business in Vancouver, Ms. King is one of Canada's most respected senior business executives. She received the award for Significant Board Contribution by the Association of Women in Finance in 2019 and was inducted into the Canada's Most Powerful Women: Top 100 Hall of Fame™ in 2010. Her dedication to leadership has earned her a reputation as a dynamic business thought-leader in the areas of corporate finance and business transformation. "On behalf of the Trust and my fellow trustees, I am very pleased to welcome Annalisa King to the board," said Gary Collins, the Trust's Chief Executive Officer and Chairman. "Annalisa's extensive audit, risk and financial experience provides a strong addition to the board. I look forward to working with her on behalf of our unitholders." With the addition of Ms. King, the Trust's board is now made up of eight members with backgrounds in the areas of pharmaceuticals, government, business, finance, law, cybersecurity and governance, all critical to the continued growth and prosperity of the Trust. The Trust is managed by DRI Capital Inc., a pioneer in global pharmaceutical royalty monetization. Since its initial public offering in 2021, the Trust has deployed more than $1.0 billion, acquiring more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. The Trust's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol " and in U.S. dollars under the symbol "DHT.U". To learn more, visit or follow us on LinkedIn.


Globe and Mail
4 days ago
- Globe and Mail
Breaking Down Thursday's Top 3 Unusually Active Options
Happy Friday to Barchart readers, everywhere. I don't know what the weather is like where you live, but here in Halifax, on Canada's east coast, we are headed into what is expected to be the 13th consecutive bad-weather weekend. It's rained every weekend since March. The rain we are receiving is much-needed in Manitoba and Saskatchewan, where wildfires have forced over 33,000 people to evacuate their homes. I sure hope some of our rain heads west sooner rather than later. They need it in a big way. On tap this morning was the Department of Labor's jobs report for May. It was decent with 139,000 jobs added last month, down from 147,000 in April, but 9,000 higher than the economists' forecast. The unemployment rate remained at 4.2%. As a result of the resilient jobs report, the S&P Futures are moving higher with about half an hour to the open. Let's see if we can finish the week on a high note. In Thursday's trading, there were 1,399 unusually active options, split almost evenly between puts (705) and calls (694). Of the top 100 by Vol/OI (volume-to-open-interest) ratios, these three had the highest. Have an excellent weekend. Visa (V) Visa's (V) Jan. 15/2027 $400 call was numero uno with a Vol/OI ratio of 81.86. The profit probability is so-so at 27.64%. The expected move is 20.17% in either direction. With nearly 20 months until expiration, there's a lot of water to go under the bridge. While analysts love the stock --of the 38 covering V stock, 33 rate it a Buy (4.63 out of 5), with a 383.81 mean target price--there is a lot that can go wrong in the global economy in the next 12-18 months resulting from tariffs and uncertain trading relationships, forcing the U.S. and other developed markets into a recession. Visa generates revenue by charging interchange fees to financial institutions that utilize its global network for processing, clearing, and settling transactions. If the economy goes into a downturn, consumers and businesses spend less, resulting in fewer financial transactions that require processing. However, Mizuho Securities analyst Dan Dolev recently upgraded V stock to Outperform (Buy) from Neutral (Hold), while raising his target price by $57 to $425, within shouting distance of the call's $437.45 breakeven. 'We see more reason for optimism as the remaining cash-to-card runway in the US is longer than previously expected,' Barron's reported Dolev's comments on June 5. 'This leaves room for another decade of solid top-line growth domestically.' As the analyst suggested, Visa and Mastercard (MA) have 'arguably the highest quality duopoly in the world,' so over the long haul, their share price should continue to move higher. Over the past 20 months (Oct. 6, 2023, through June 5, 2025), Visa's shares have appreciated by 56%. To break even on the Jan. 15/2025 $400 call, it needs only to appreciate by 18.64%. That is very doable. With a net debit of $3,705, just 9.2% of the $400 strike, the risk/reward proposition is more than reasonable. If Novo Nordisk (NVO) The Danish maker of Ozempic and Wegovy had the second-highest Vol/OI ratio yesterday of 71.77. The volume of 12,129 accounted for nearly 23% of the overall total. The 53,351 was the stock's highest daily volume since May 19. Of the 12,129 contracts traded for the June 13 $66 put, one order accounted for 85% of the volume. Some big hitter had a hunch. Novo Nordisk's (NVO) stock appears to have bottomed in mid-April at $57. It's up 27% in the seven weeks since. Barchart's Technical Opinion rates it a 40% Sell with the 20-day moving average signaling Buy. In mid-May, the company's board ousted CEO Lars Fruergaard Jorgensen after eight years running the drugmaker. Jorgensen had spent his entire career with Novo Nordisk. There is no question that, at least in the past 6-12 months, the bloom has come off the rose for NVO stock. With poor results for CagriSema, its next-generation weight-loss drug set for release in 2026, increased competition in the weight loss space from Eli Lilly (LLY), and lower growth forecasts, it will be some time before investors pile back on to the Novo Nordisk train. However, with just a 7.54% profit probability from the long put bet, the big hitter was likely counting on a virtually guaranteed, 10.5% annualized return by selling the puts instead. Worst case scenario: They're able to buy NVS stock at a slightly lower entry point should it fall below $66, and the buyer exercises their right to sell. I like that trade a lot. Roblox (RBLX) This last one should be filed under 'a wing and a prayer' or 'Hail Mary,' with a profit probability of just 3.13%. Roblox (RBLX) stock would have to drop by nearly 20% in the next week to have any chance of profiting from the $76 put strike. I can't remember the last time I wrote about Roblox, whose online platform allows users to create, share, and play virtual experiences and games. RBLX stock is alive and well, trading up 66% in 2025 and 169% over the past 12 months. Over the past five years, on three occasions (June 2022, December 2022, and September 2023), its shares traded at around $27. They're now not too far off from the November 2021 all-time high of $141.60. Roblox has hit 63 new 52-week highs in the past 12 months. Of the 24 analysts covering its stock, 16 rate it a Buy (4.13 out of 5), with a mean target price of $76.88, well below its current share price. I'm often confused by analysts assigning a Buy rating to a stock but with a target price below its current share price. I realize this means that the bullish analysts feel its share price has gotten ahead of itself. So, why not rate it Hold? That's a discussion for another day. As the company stated in May, it anticipates generating as much as $930 million in free cash flow in 2025, based on $4.37 billion in revenue, resulting in a 21.3% margin, the highest levels for both in its history. Yes, it still is losing a bundle--Roblox guidance calls for a net loss in 2025 between $977 million and $1.04 billion--but positive free cash flow is the name of the game and it could go over $1 billion as early as this year with a bit of luck, but definitely in 2026. Even if it loses $1 billion annually for the next three years, Roblox has sufficient liquidity to maintain operations—net cash of $3.5 billion as of March 31—so it remains an attractive stock for speculative investors. If you sold the $76 put for $0.02 in premium income, your annualized return on the bet would be 1.4% [0.02 / $76 * 365 / 8]. Long or short, I'm not sure why someone made a trade for 7,000 $76 put contracts yesterday. There doesn't seem to be a profitable outcome either way. Of course, at $15 a contract, it's not a significant outlay. No harm, no foul, I guess.